Gastrointestinal Diseases  >>  epirubicin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00825669: Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Completed
N/A
100
RoW
TACE, TAE, Laser ablation, Microinvasive
Eastern Hepatobiliary Surgery Hospital
Hepatocellular Carcinoma
12/09
12/10
mEGA, NCT02358863: Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach

Terminated
N/A
13
US
Modified FOLFOX6, Oxaliplatin, Eloxatin, Leucovorin, 5-FU, 5-Flourouracil, Docetaxel/Capecitabine, Taxotere, Xeloda, Cisplatin/Irinotecan, Platinum, CPT-11, Camptosar, Cisplatin/Docetaxel, IRI/EPI, Irinotecan, Epirubicin, EPI/Docetaxel, Irinotecan/Docetaxel, Docetaxel
Georgetown University
Esophageal Cancer, Gastric Cancer
11/16
11/16

Download Options